Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic form of systemic vasculopathy that often presents during early childhood. Linked to biallelic mutations in ADA2 (previously CECR1), DADA2 was initially described as a syndrome of recurrent fever, livedo racemosa, early-onset strokes, and per...
Saved in:
Main Author: | Pui Y. Lee (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of severe combined immunodeficiency caused by adenosine deaminase deficiency with a new mutation
by: Ozden Turel, et al.
Published: (2018) -
Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
by: Secord E, et al.
Published: (2022) -
Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)
by: Katherine Clarke, et al.
Published: (2019) -
Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency
by: M.B. Ates, et al.
Published: (2023) -
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China
by: Wei Wang, et al.
Published: (2021)